Risedronic acid is a bisphosphonate used to treat bone diseases such as osteoporosis and Paget's disease. It works by inhibiting the activity of osteoclasts, cells responsible for bone resorption, which helps to strengthen bones and prevent fractures. Risedronic acid is typically administered orally or via intravenous injection.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Risedronic Acid and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Risedronic Acid impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Risedronic Acid-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
Chemical Name: [(3RS,6RS and 3R,6S-meso)-2,5-dihydroxy-2,5-dioxo-3,6-bis[(pyridin-3-yl)methyl]-1,4,2?5,5?5-dioxadiphosphinane-3,6-diyl]bis(phosphonic acid)
Chemical Name: [(2?,3?,5?,6?)-2,5-dihydroxy-2,5-dioxo-3,6-bis[(pyridin-3-yl)methyl]-1,4,2?5,5?5-dioxadiphosphinane-3,6-diyl]bis(phosphonic acid) disodium tetrahydrate (as per EP) ; [3,6-Bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt (as per USP)
.jpg)
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
acetate.jpg)
acetic acid.jpg)
